Oncolytics Biotech Inc ONCY

ONCY to present Spotlight Presentation - Dec7th @ SABC 2022

[Noteable]

Spotlight Session Poster Presenters are required to produce and upload both a virtual poster and printed poster so that the Spotlight Chair and Discussants have both for review and discusion at the time of the presentation

[Noteable]

Each Spotlight Poster Discussion Session will consist of 2-3 sub-topic groups of posters, with a discussant for each group. Generally, posters on video screens will be viewed at the beginning of each session. Then each discussant will speak about the posters in his or her group followed by questions addressed by the discussant and the poster presenters. 

[Noteable]

Title: Pelareorep Primes the Tumor for Checkpoint Inhibition Therapy by Activating the Interferon-Gamma Signaling Pathway and Tumor Inflammation Signature in Early Breast Cancer Patients - Results of the AWARE-1 Trial Program Number: PD4-03 Session Title: Spotlight Poster Discussion 4 Session Date: December 7, 2022 Session Time: 7 a.m. CT Described in this abstract